Author: Ottilie S

References 8 references

Ottilie S, et al. (2022) Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance. Commun Biol 5(1):128 PMID:35149760
LaMonte GM, et al. (2020) Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway. Nat Commun 11(1):1780 PMID:32286267
Ottilie S, et al. (2018) Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapies. J Cheminform 10(1):6 PMID:29464421
Ottilie S, et al. (2017) Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive Yeast. ACS Chem Biol 12(2):422-434 PMID:27977118
Goldgof GM, et al. (2016) Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor. Sci Rep 6:27806 PMID:27291296
Sells MA, et al. (1998) Characterization of Pak2p, a pleckstrin homology domain-containing, p21-activated protein kinase from fission yeast. J Biol Chem 273(29):18490-8 PMID:9660818
Ottilie S, et al. (1995) Fission yeast pak1+ encodes a protein kinase that interacts with Cdc42p and is involved in the control of cell polarity and mating. EMBO J 14(23):5908-19 PMID:8846783
Hannig G, et al. (1993) Comparison of the biochemical and biological functions of tyrosine phosphatases from fission yeast, budding yeast and animal cells. Yeast 9(10):1039-52 PMID:8256510